Loading company…
Shanghai-based provider of drug research, development, production and testing services, including chemical and biological research.
Established in 2000 and based in Shanghai, China, WuXi AppTec Co., Ltd. provides pharmaceutical R&D services for new drugs and medical devices, with branch offices in South Korea, Japan and Singapore. Its shares are listed in Shanghai and Hong Kong, and Li Ge is CEO. In December 2024, Altaris agreed to acquire the group's Advanced Therapies Unit, with financial terms not disclosed. It is listed at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in